Literature DB >> 17443388

Factors affecting successful breast conservation for ductal carcinoma in situ.

Mary F Dillon1, Enda W Mc Dermott, Ann O'Doherty, Cecily M Quinn, Arnold D Hill, Niall O'Higgins.   

Abstract

BACKGROUND: Successful breast-conserving therapy in DCIS is restricted by high rates of residual disease resulting in the need for radiotherapy and/or re-excision. This study identifies patients with DCIS who are most at risk of compromised margins and of residual disease.
METHODS: All patients undergoing breast-conserving surgery for DCIS over a 6-year period were included. Method of diagnosis, mammographic size, pathological size, DCIS-margin distance and residual disease on re-excision were analysed.
RESULTS: One hundred and thirty-five patients underwent initial breast-conserving surgery for DCIS. The compromised margin rate was 72%, and the rate of residual disease on re-operation was 54%. On univariate analysis, underestimation of pathological size by mammography by >1 cm occurred in 40% of those with compromised margins undergoing a therapeutic operation compared to only 14% of those with clear margins (P = 0.02). However, on multivariate analysis only pathological size (P < 0.0001, OR = 1.0,95% CI 1.037-1.128) and lack of a preoperative diagnosis by core biopsy (P < 0.0001, OR = 5.3,95% CI 1.859-15.08) were predictive of compromised margins. The presence of residual disease on re-excision was associated with increasing pathological size (P < 0.0001, OR = 1.085,95% CI 1.038-1.134) and decreasing DCIS-margin distance (P = 0.03, OR = 6.694,95% CI 1.84-37.855). Twenty-nine percent (n = 13/45) of lesions < or =3 cm compared to 84% (n = 27/32) of lesions >3 cm had residual disease on re-operation (P < 0.0001). Residual disease was present in 62% (n = 34/55), 64% (n = 7/11) and 17% (n = 2/12) of patients with DCIS-margin distances < or =1, 1-2 and 2-5 mm, respectively.
CONCLUSION: Considerable underestimation of DCIS extent by mammography occurs in a high proportion of patients with compromised margins in breast conservation. Patients at particularly high risk of residual disease on re-excision are those with lesions >3 cm and those with DCIS-margin distances of < or = 2mm.

Entities:  

Mesh:

Year:  2007        PMID: 17443388     DOI: 10.1245/s10434-006-9246-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  23 in total

1.  An immersed boundary method for simulating a single axisymmetric cell growth and division.

Authors:  Yibao Li; Ana Yun; Junseok Kim
Journal:  J Math Biol       Date:  2011-10-11       Impact factor: 2.259

2.  Assessing breast tumor margin by multispectral photoacoustic tomography.

Authors:  Rui Li; Pu Wang; Lu Lan; Frank P Lloyd; Craig J Goergen; Shaoxiong Chen; Ji-Xin Cheng
Journal:  Biomed Opt Express       Date:  2015-03-12       Impact factor: 3.732

Review 3.  Diagnosing clean margins through Raman spectroscopy in human and animal mammary tumour surgery: a short review.

Authors:  I A Birtoiu; C Rizea; D Togoe; R M Munteanu; C Micsa; M I Rusu; M Tautan; L Braic; L O Scoicaru; A Parau; N D Becherescu-Barbu; M V Udrea; A Tonetto; R Notonier; C E A Grigorescu
Journal:  Interface Focus       Date:  2016-12-06       Impact factor: 3.906

4.  AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2014.

Authors:  Cornelia Liedtke; Marc Thill; Volker Hanf; Florian Schütz
Journal:  Breast Care (Basel)       Date:  2014-07       Impact factor: 2.860

Review 5.  New technologies in breast cancer surgery.

Authors:  Marc Thill; Kristin Baumann
Journal:  Breast Care (Basel)       Date:  2012-10       Impact factor: 2.860

6.  Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes.

Authors:  Stacy R Millon; Julie H Ostrander; Siavash Yazdanfar; J Quincy Brown; Janelle E Bender; Anita Rajeha; Nirmala Ramanujam
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

7.  Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression.

Authors:  Paul Macklin; Mary E Edgerton; Alastair M Thompson; Vittorio Cristini
Journal:  J Theor Biol       Date:  2012-02-09       Impact factor: 2.691

Review 8.  Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ.

Authors:  Nita Amornsiripanitch; Diana L Lam; Habib Rahbar
Journal:  Semin Roentgenol       Date:  2018-08-30       Impact factor: 0.800

9.  Predictors of Reexcision following Breast-Conserving Surgery for Ductal Carcinoma In Situ.

Authors:  Leslie R Lamb; Sarah Mercaldo; Tawakalitu O Oseni; Manisha Bahl
Journal:  Ann Surg Oncol       Date:  2020-09-10       Impact factor: 5.344

10.  High and intermediate grade ductal carcinoma in-situ of the breast: a comparison of pathologic features in core biopsies and excisions and an evaluation of core biopsy features that may predict a close or positive margin in the excision.

Authors:  Oluwole Fadare; Nathan F Clement; Mohiedean Ghofrani
Journal:  Diagn Pathol       Date:  2009-08-19       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.